Actively Recruiting

Age: 2Years - 14Years
All Genders
NCT07032857

Intestinal Permeability in Children With Autism Spectrum Disorder

Led by University of Bari · Updated on 2025-06-27

55

Participants Needed

1

Research Sites

143 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In recent years, increasing attention has been directed toward the role of the gut-brain axis in the pathogenesis of neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD). Among the multiple contributing factors, the integrity of the intestinal barrier appears to play a crucial role. Enhanced paracellular permeability ("leaky gut") may allow luminal antigens and microbial metabolites to translocate into the systemic circulation, triggering inflammatory responses that could impact neuropsychological functioning. Several studies suggest that, although intestinal permeability is not universally altered in all individuals with ASD, there exists a subset characterized by selective epithelial dysfunction, especially associated with repetitive and stereotyped behaviors. This project aims to investigate, through a controlled sibling-based design, whether intestinal permeability indices are significantly altered in children with ASD and whether such alterations are specifically correlated with behavioral domains assessed through the ADOS instrument.

CONDITIONS

Official Title

Intestinal Permeability in Children With Autism Spectrum Disorder

Who Can Participate

Age: 2Years - 14Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children with a clinical diagnosis of ASD according to DSM-IV, confirmed by ADOS-G
  • Consumption of a gluten-containing diet
  • Negative celiac disease serology (EMA and anti-TG2 IgA antibodies)
  • Absence of IgE- or non-IgE-mediated food allergies
Not Eligible

You will not qualify if you...

  • Known neurological disorders
  • Major congenital anomalies
  • Severe head trauma
  • Chronic gastrointestinal diseases
  • Special diets (e.g., gluten-free or gluten/casein-free)
  • Antibiotic or probiotic/prebiotic intake in the previous 4 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Of Bari Aldo Moro

Bari, BA, Italy, 70126

Actively Recruiting

Loading map...

Research Team

R

Ruggiero Francavilla, Prof

CONTACT

F

fernanda Cristofori, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here